In our department, stroke accounts for approximately half of all cases, and we provide medical care across the entire field of Department of Neurology, from dynamic diseases such as acute cerebrovascular disorders to static diseases such as neurodegenerative diseases, neuroimmunological diseases, and peripheral neuropathy.

In particular, for cerebral infarction, we provide advanced acute care 24 hours a day in cooperation with the emergency medical center and Neurosurgery, including rt-PA intravenous therapy and endovascular treatment by endovascular specialists. In almost all cases, we perform MRI, MR angiography, carotid artery and cardiac echocardiography, and Holter ECG, and add transesophageal echocardiography as needed to determine the appropriate treatment plan. Furthermore, for cryptogenic cerebral infarction, we implant an implantable electrocardiogram recorder (Reveal LINQ) to actively search for the source of the embolus.

For Parkinson's disease, in addition to the latest drug therapies, we have introduced advanced treatments such as deep brain stimulation (DBS), enteral levodopa/carbidopa therapy (LCIG), and continuous subcutaneous infusion therapy (Vialev) for refractory cases. For neuroimmunological diseases such as multiple sclerosis and neuromyelitis optica, in addition to acute treatments such as steroid pulse therapy, specialists provide treatment based on the latest knowledge, including various disease-modifying drugs (DMDs) aimed at preventing relapses. We also offer advanced treatments for myasthenia gravis, including antibody therapies developed in recent years.

In dementia care, our hospital, as the only core Dementia Treatment Department in the prefecture, promotes collaboration with various facilities and local medical institutions throughout the prefecture. We utilize PET scans for the diagnosis of Alzheimer's disease and also offer novel antibody therapies for mild cognitive impairment (MCI).

For peripheral neuropathy, we actively implement immunoglobulin maintenance therapy, home self-injection (SCIG), and anti-FcRn antibody therapy for Guillain-Barré syndrome and CIDP. For migraines, we provide the latest treatments, such as CGRP-related antibody preparations, based on precise diagnoses by headache specialists. For status epilepticus, in severe cases, we perform electroencephalography (EEG) and other tests under ICU management to provide appropriate treatment.

Furthermore, for infectious diseases such as meningitis, we strive for early diagnosis and treatment by performing rapid imaging and cerebrospinal fluid examinations. In addition, we offer the latest treatments, including nucleic acid drugs, for rare diseases such as familial amyloid neuropathy (FAP).

Our department actively conducts clinical trials for various diseases in order to bring the latest treatment technologies back to patients. Furthermore, we have established a system capable of handling a wide range of intractable neurological diseases, including hereditary disorders, and we also provide genetic counseling by clinical genetic specialists.